2022 Woman of Distinction Honoree

Marcy provides strategic investor relations and corporate communications counsel to public and private emerging life science companies with the goal of increasing shareholder value and corporate visibility. She has advised over 60 biotechnology companies across a number of therapeutic categories on how to effectively communicate their clinical development plans, business strategy and financial profile to investors, partners and boards of directors. Additionally, she has deep relationships with healthcare investors, equity research analysts and investment bankers on Wall Street.

Marcy currently serves at the vice president of corporate affairs for Strongbridge Biopharma plc, a global biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs. Previously, she was a managing director at Solebury Trout, a boutique investor relations and corporate communications firm. Marcy holds a bachelor’s in business administration in finance, consulting and venture management from Emory University’s Goizueta School of Business, and holds Series 7, 79 and 63 securities licenses. She is also on the National Board of Directors for the Crohn’s and Colitis Foundation and is the co-founder and program director of the Foundation’s New York Camp Oasis.